Papers: 10.1371/journal.ppat.1007246

https://doi.org/10.1371/journal.ppat.1007246

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication

Cited by: 29
Author(s): Krystelle Nganou-Makamdop, James M. Billingsley, Zak A. Yaffe, Gregory O’Connor, Gregory K. Tharp, Amy Ransier, Farida Laboune, Rodrigo Matus‐Nicodemos, Andrea M Lerner, Lavina Gharu, Jennifer Rosenstein, Mandy L. Ford, Martin Schlapschy, Nadine Kuhn, Alexandra Lensch, Jeffrey D. Lifson, Martha Nason, Arne Skerra, Gideon Schreiber, Steven E. Bosinger, Daniel C. Douek
Published: about 8 years ago

Software Mentions 1